GenAI in Insurance: 3 key takeaways from a global industry survey

Nearly 250 insurance decision makers share intel on GenAI strategy, sentiment and innovation Will generative AI prove itself a bane or boon to the insurance industry? A new study exploring the use of generative AI in insurance suggests that 9 in 10 insurers plan to invest in GenAI in the next year. The enthusiasm is […]

Double Double: October 15th Canada Carbon Rebate delivers boost for rural families

Today, families across Canada will receive their Canada Carbon Rebate, a payment that is making life more affordable for Canadians. The Canada Carbon Rebate-alongside measures like dental care, child care, and others-contribute to the Government of Canada’s plan to help Canadian families get ahead while ensuring big polluters pay their fair share. Today, the Honourable

Bronstein, Gewirtz & Grossman, LLC Encourages The Toronto Dominion Bank (TD) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Toronto Dominion Bank ("TD Bank" or "the Company") (NYSE:TD). Investors who purchased TD Bank securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

Neurogenomics Market to Reach $4.68 Billion by 2031–Exclusive Report by Meticulous Research®

According to a new market research report titled,’Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering (NGS [Kits {Library Prep, QC, DNA Extraction}, Systems], PCR, Microarrays {Protein, DNA, RNA, Tissue}, Software) Application (Research, Clinical) End User-Global Forecast to 2031. https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg The neurogenomics market is expected to reach $4.68 billion by 2031, at a CAGR

Oil Prices Fall 4% As Middle East Tensions Ease

%Oil prices are down 4% and at their lowest level in two weeks as tensions across the Middle East subside and demand in China weakens. The price of crude oil fell sharply on media reports that Israel does not plan to strike Iranian oil fields in retaliation for missiles fired at the country in recent

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Roblox Corporation (RBLX) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Roblox Corporation ("Roblox" or "the Company") (NYSE:RBLX). Investors who purchased Roblox securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RBLX. Investigation Details

Canal Road Group Closes $250 Million Credit Facility with Wells Fargo for Private Corporate Lending Strategy

Canal Road has closed a new $250 million credit facility agented by Wells Fargo Bank, N.A. The financing increases the firm’s investible capital to be deployed in the private corporate lending market. Canal Road’s inaugural strategy predominantly targets 1st Lien and unitranche corporate loans for companies with EBITDA of $50 million or more in North

Iris Energy Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Block & Leviton announces that a securities fraud lawsuit has been filed against Iris Energy Ltd (Nasdaq: IREN) and certain of its executives. Investors who have lost money in their Iris Energy Ltd investment should contact the firm to learn more about how they might recover those losses.

Toll Brothers Campus Living(R) Opens Kinetic, a New Luxury Student Apartment Community in Atlanta

ATLANTA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Toll Brothers Campus Living(R), a division of Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, announces the opening of Kinetic in Atlanta. Kinetic is a new off-campus apartment community designed exclusively for college students, featuring 239 apartment homes with 752 beds. The community is

Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting

On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The abstract of the Phase II clinical study (CGZ203 trial) on the treatment of non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (MASH) with our independently developed

Scroll to Top